MDRX:NGS-Allscripts Healthcare Solutions Inc. (USD)

EQUITY | Health Information Services | Nasdaq Global Select

Last Closing

USD 9.8

Change

+0.29 (+3.05)%

Market Cap

USD 2.05B

Volume

1.60M

Analyst Target

USD 9.97
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Allscripts Healthcare Solutions Inc is a provider of clinical, financial, connectivity and information solutions and related professional services that empower hospitals, physicians and post-acute organizations to deliver world-class outcomes.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-13 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
GEHC GE HealthCare Technologies Inc..

+0.15 (+0.17%)

USD 38.86B
HQY HealthEquity Inc

+0.55 (+0.70%)

USD 6.83B
RCM R1 RCM Inc

-0.02 (-0.14%)

USD 5.96B
GDRX Goodrx Holdings Inc

-0.09 (-1.17%)

USD 2.94B
BTSG BrightSpring Health Services, ..

+0.72 (+5.17%)

USD 2.37B
PRVA Privia Health Group Inc

+0.11 (+0.59%)

USD 2.23B
PINC Premier Inc

-0.23 (-1.11%)

USD 2.03B
OMCL Omnicell Inc

+0.05 (+0.11%)

USD 1.99B
CERT Certara Inc

+0.13 (+1.21%)

USD 1.76B
SDGR Schrodinger Inc

-0.24 (-1.21%)

USD 1.48B

ETFs Containing MDRX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -6.58% 63% D 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.58% 63% D 40% F
Trailing 12 Months  
Capital Gain -19.74% 59% D- 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -19.74% 59% D- 33% F
Trailing 5 Years  
Capital Gain -6.13% 63% D 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.13% 63% D 41% F
Average Annual (5 Year Horizon)  
Capital Gain 16.21% 78% C+ 74% C
Dividend Return 16.21% 77% C+ 73% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 59.45% 27% F 30% F
Risk Adjusted Return 27.26% 78% C+ 61% D-
Market Capitalization 2.05B 78% C+ 72% C

Key Financial Ratios

  Ratio vs. Industry/Classification (Health Information Services) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 11.22 79% 68%
Price/Book Ratio 0.88 73% 75%
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio 2.53 47% 47%
Management Effectiveness  
Return on Equity 8.93% 95% 76%
Return on Invested Capital N/A N/A N/A
Return on Assets 2.16% 84% 75%
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.